SLC2A4RG

Across TCGA pan-cancer cohorts, SLC2A4RG Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated SLC2A4RG data layer compared with 24 for mass-spec protein and 1 for mass-spec protein.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher SLC2A4RG Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated SLC2A4RG expression acts as an unfavorable survival marker.

STAD, LUSC, and UCEC are the cancer types where SLC2A4RG Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Median	All	0.003	0.688	<.001	36	view →
LUSC	OS	Median	All	0.156	0.675	.014	24	view →
UCEC	OS	Median	IV	0.066	0.755	<.001	12	view →
LIHC	DFS	Median	All	0.150	0.529	.041	9	view →
KIRC	OS	Median	All	0.178	0.655	.042	6	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

SLC2A4RG–STAD (OS)

Open the STAD breakdown →